Your #1 Source for Life Extension News
Lifespan.io offers the latest information on rejuvenation biotechnology and life extension technologies. Our news outlet brings you the latest aging research, financial, and advocacy news, which is great if you like to keep up to date with everything happening in this rapidly changing field on a daily basis.
The Latest Longevity News Stories
New Drug Eliminates Breast Cancer in a Single Dose
Researchers have discovered a small molecule that effectively kills cancer cells in the most prevalent type of breast cancer. The new drug could help against cancer recurrence and decrease the need for […]
Marco Quarta on Cellular Senescence in Aging
Dr. Marco Quarta runs one of the most interesting start-ups in the longevity field: Rubedo, which focuses on utilizing the senolytic approach to […]
Maintaining Muscle by Restoring Gut Bacteria
In Aging Cell, researchers have described how different combinations of gut bacteria impact muscle strength in mice. Expanding upon a known link The link between […]
Cyclarity Launches Human Trial to Cure Atherosclerosis
Recently, Cyclarity Therapeutics announced the launch of a Phase 1 human clinical trial for a drug that aims to remove the arterial plaques that lead to heart attacks and strokes. Tackling the leading cause of death […]
Maintaining Telomeres Extends Lifespan in Mice
A recent study has found that the overexpression of telomerase reverse transcriptase (TERT), which is a subunit of telomerase, an enzyme essential for telomere maintenance, leads to […]
Fighting Alzheimer’s by Helping Neurons Consume Proteins
Researchers have found that kinesin family member 9 (KIF9), a protein that diminishes with aging, is instrumental in allowing cells to consume harmful proteins and fights Alzheimer’s in a mouse model. Consuming amyloids before they become a […]
New Study Links Epigenetic Changes to Genetic Mutations
A new paper published in Nature Aging suggests that somatic mutations cause significant remodeling of the epigenetic landscape. The findings might be relevant to future anti-aging interventions [1]. The genome and the […]
The Battle for Long Life Has Been Accomplished: What’s Next?
How long can people live? This is not just a foundational question in science. The answer has important public policy implications and is of interest to us all. […]
Enhancing NAD+ Efficiency by Energizing Sirtuins
Researchers publishing in Physical Review X have discovered compounds that can double the efficiency of the sirtuin SIRT3 in processing NAD+. Looking for a new way […]
The Impact of a Human Breast Milk Probiotic on Sarcopenia
A recent study linked probiotic-induced gut microbiome and metabolite changes to improved muscle functioning in older sarcopenia patients [1]. Sarcopenia and the gut […]
A Gut Metabolite Reduces Senescence and Inflammation
In a preprint study, scientists from Lifespan Research Institute and the Buck Institute for Research on Aging have published their findings that Urolithin A, a molecule that has garnered a lot of attention in the longevity field, potently reduces […]
Cyclarity Launches Human Trial for Atherosclerosis
Cyclarity Therapeutics, a biotechnology company based at the Buck Institute in California, has launched its first human clinical trial. Its primary candidate cyclodextrin drug, UDP-003, focuses on 7-ketocholesterol, an oxidized cholesterol variant that builds up in cells as we age. […]
Interviewing the leading experts in aging research and longevity
We have a dedicated team of journalists who have interviewed many of the leaders in the field about their research and the drive to end age-related diseases. You can find our latest interviews below.
Regular Digest Articles
We publish the Rejuvenation Roundup – a monthly digest of what is happening in the field, a Longevity Market Recap – a monthly digest focused on the investment and business side of the field, and a quarterly Editorial – focusing on the activities of the news outlet and the wider organization.
Industry Press Releases
You can find some press releases from various companies in our field below. Lifespan.io does not endorse any of these PRs and they are simply provided for information and interest.
Want even more news?
If you want to see even more recent articles, check out all news stories, or if you would like to look at a specific year or month head to the news archive.
